Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Identification of beta-1 adrenergic receptor polymorphisms in cats.

Maran BA, Meurs KM, Lahmers SM, Nelson OL.

Res Vet Sci. 2012 Aug;93(1):210-2. doi: 10.1016/j.rvsc.2011.05.007. Epub 2011 Jun 12.

PMID:
21669447
2.

Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.

Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF Jr, Hill JA, Aranda JM Jr, Johnson JA.

Pharmacogenet Genomics. 2007 Apr;17(4):277-82.

PMID:
17496726
3.

The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.

Muszkat M, Hoofien A, Orlanski-Meyer E, Makhoul H, Porat E, Davidson EM, Blotnick S, Caraco Y.

Pharmacogenet Genomics. 2013 Jan;23(1):25-8. doi: 10.1097/FPC.0b013e32835afde6.

PMID:
23114278
4.

Identification of DNA variants in the canine beta-1 adrenergic receptor gene.

Maran BA, Mealey KL, Lahmers SM, Nelson OL, Meurs KM.

Res Vet Sci. 2013 Aug;95(1):238-40. doi: 10.1016/j.rvsc.2013.02.021. Epub 2013 Apr 6.

PMID:
23566791
5.

Impact of the canine double-deletion β1 adrenoreceptor polymorphisms on protein structure and heart rate response to atenolol, a β1-selective β-blocker.

Meurs KM, Stern JA, Reina-Doreste Y, Maran BA, Chdid L, Lahmers S, Keene BW, Mealey KL.

Pharmacogenet Genomics. 2015 Sep;25(9):427-31. doi: 10.1097/FPC.0000000000000152.

PMID:
26065525
6.

β(1)-Adrenergic receptor gene polymorphisms and the acute response to atenolol in healthy young Japanese subjects.

Sasaguri T, Shiraishi F, Yoshihara T, Takahashi-Yanaga F, Morimoto S.

J Pharmacol Sci. 2011;115(4):490-9. Epub 2011 Mar 16.

7.

Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.

Yilmaz A, Kaya MG, Merdanoglu U, Ergun MA, Cengel A, Menevse S.

J Clin Lab Anal. 2009;23(4):237-43. doi: 10.1002/jcla.20327.

PMID:
19623647
8.

Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.

Kang S, Hong X, Ruan CW, Yu P, Yu SS, Chen M, Zhang DF, Fan HM, Liu ZM.

J Transl Med. 2015 Feb 1;13:44. doi: 10.1186/s12967-015-0402-7.

9.

Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.

Magnusson Y, Levin MC, Eggertsen R, Nyström E, Mobini R, Schaufelberger M, Andersson B.

Clin Pharmacol Ther. 2005 Sep;78(3):221-31.

PMID:
16153393
10.

Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro.

Molenaar P, Rabnott G, Yang I, Fong KM, Savarimuthu SM, Li L, West MJ, Russell FD.

J Am Coll Cardiol. 2002 Oct 2;40(7):1275-82.

11.

Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.

Wu D, Li G, Deng M, Song W, Huang X, Guo X, Wu Z, Wu S, Xu J.

J Int Med Res. 2015 Jun;43(3):424-34. doi: 10.1177/0300060514563151. Epub 2015 Mar 30.

PMID:
25823457
12.

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.

Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA.

Pharmacogenet Genomics. 2005 Apr;15(4):227-34.

PMID:
15864115
13.

Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.

Suonsyrjä T, Donner K, Hannila-Handelberg T, Fodstad H, Kontula K, Hiltunen TP.

Pharmacogenet Genomics. 2010 May;20(5):342-5. doi: 10.1097/FPC.0b013e328338e1b8.

PMID:
20300048
14.

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors.

Liggett SB.

Pharmacology. 2000 Sep;61(3):167-73. Review.

PMID:
10971202
15.

Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.

Iwai C, Akita H, Kanazawa K, Shiga N, Terashima M, Matsuda Y, Takai E, Miyamoto Y, Shimizu M, Kajiya T, Hayashi T, Yokoyama M.

Am Heart J. 2003 Jul;146(1):106-9.

PMID:
12851615
16.

Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.

Fu C, Wang H, Wang S, Shi Y, Zhou X, Sun K, Chen J, Song X, Xue H, Hui R.

Clin Biochem. 2008 Jul;41(10-11):773-8. doi: 10.1016/j.clinbiochem.2008.02.002. Epub 2008 Feb 15.

PMID:
18298953
17.

Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma.

Inagaki Y, Mashima Y, Fuse N, Funayama T, Ohtake Y, Yasuda N, Murakami A, Hotta Y, Fukuchi T, Tsubota K.

Mol Vis. 2006 Jun 12;12:673-80.

18.

Methylation of adrenergic β1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol.

Jiang Q, Yuan H, Xing X, Liu J, Huang Z, Du X.

Indian J Biochem Biophys. 2011 Oct;48(5):301-7.

PMID:
22165287
19.

Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.

Kardia SL, Kelly RJ, Keddache MA, Aronow BJ, Grabowski GA, Hahn HS, Case KL, Wagoner LE, Dorn GW 2nd, Liggett SB.

BMC Med Genet. 2008 Oct 23;9:93. doi: 10.1186/1471-2350-9-93.

20.

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF.

Clin Pharmacol Ther. 2003 Jul;74(1):44-52.

PMID:
12844134

Supplemental Content

Support Center